Precipio Inc PRPO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/11/22 EDT
1.51quote price arrow down-0.02 (-1.31%)
Volume
12,763
Close
1.53UNCH (UNCH)
Volume
55,257
52 week range
0.91 - 4.17
Loading...
  • Open1.57
  • Day High1.62
  • Day Low1.52
  • Prev Close1.52
  • 52 Week High4.17
  • 52 Week High Date08/26/21
  • 52 Week Low0.91
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap34.75M
  • Shares Out22.71M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta2.14
  • YTD % Change-3.16

KEY STATS

  • Open1.57
  • Day High1.62
  • Day Low1.52
  • Prev Close1.52
  • 52 Week High4.17
  • 52 Week High Date08/26/21
  • 52 Week Low0.91
  • 52 Week Low Date05/12/22
  • Market Cap34.75M
  • Shares Out22.71M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta2.14
  • YTD % Change-3.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-2.93
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-11.12M
  • ROE (TTM)-63.52%
  • Revenue (TTM)9.47M
  • Gross Margin (TTM)27.73%
  • Net Margin (TTM)-122.99%
  • Debt To Equity (MRQ)2.27%

EVENTS

  • Earnings Date08/22/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Precipio Inc

There is no recent news for this security.

Profile

MORE
Precipio, Inc. is a healthcare solutions company that is focused on cancer diagnostics. The Company is focused on developing various technologies including IV-Cell, HemeScreen and ICE-COLD-PCR (ICP). The IV-Cell is a cell culture media that addresses the problem of selective and serial culturing. IV-Cell is a media that enables culturing of all four hematopoietic cell lineages, which include myeloid cells, B-cells, T-cells and plasma cells. The diagnostic process of...
Richard Sandberg
Independent Chairman of the Board
Ilan Danieli
Chief Executive Officer, Founder, Director
Ahmed Zaki Sabet
Chief Operations Officer
Matthew Gage
Interim Chief Financial Officer
Address
12325 Emmet St
Omaha, NE
68164-4243
United States

Top Peers

SYMBOLLASTCHG%CHG
SGTX
Sigilon Therapeutics Inc
0.7495UNCHUNCH
SPRO
Spero Therapeutics Inc
0.779UNCHUNCH
APVO
Aptevo Therapeutics Inc
4.40UNCHUNCH
ERYP
Erytech Pharma SA
1.21UNCHUNCH
AGLE
Aeglea Bio Therapeutics Inc
0.4999UNCHUNCH